Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Radiation Oncology Journal
>
2017
>
35
>
3
Volume:
35
Issue:
3
1. Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
Page:289—294
2. Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation.
Page:281—288
3. Gross tumor volume dependency on phase sorting methods of four-dimensional computed tomography images for lung cancer.
Page:274—280
4. Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
Page:268—273
5. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.
Page:257—267
6. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.
Page:249—256
7. Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer.
Page:241—248
8. Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
Page:289—294
9. Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Page:233—240
10. Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation.
Page:281—288
11. Clinical significance of the lymph node ratio in N1 breast cancer.
Page:227—232
12. Gross tumor volume dependency on phase sorting methods of four-dimensional computed tomography images for lung cancer.
Page:274—280
13. Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
Page:217—226
14. Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
Page:268—273
15. Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer.
Page:208—216
16. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.
Page:257—267
17. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials.
Page:198—207
18. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.
Page:249—256
19. Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination.
Page:189—197
20. Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer.
Page:241—248
21. Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Page:233—240
22. Clinical significance of the lymph node ratio in N1 breast cancer.
Page:227—232
23. Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
Page:217—226
24. Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer.
Page:208—216
25. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials.
Page:198—207
26. Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination.
Page:189—197
